Furthermore, FGF-23 has been associated with endothelial dysfunction and vascular calcification, which, in cooperation with vascular calcification promoted by VKA use, can lead to faster progression of CKD and an increase of AF incidence. The gene discussed is FGF23; the disease is chronic kidney disease.